Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-22 to 2024-03-25
Current total value of award: $1270.3
Description: 4564054703!QUILLIVANT XR 25 MG/5 ML SUSP 120ML